Ensysce Biosciences, Inc. — Form D
Ensysce Biosciences, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-08. The offering totals $8.5M, of which $4.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-07-08
- Form: D
- Accession: 0001493152-22-018942
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $4.2M
- Remaining: $4.2M
- Investors: 3
- Date of first sale: 2022-06-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-451712
Issuer
- Name: Ensysce Biosciences, Inc.
- CIK: 0001716947
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 7946 IVANHOE AVE,, LA JOLLA, CA, 92037
- Phone: (858) 263-4196
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| D Lynn Kirkpatrick | Director | La Jolla, CA |
| D Lynn Kirkpatrick | Executive Officer | La Jolla, CA |
| David Lynn Humphrey | Executive Officer | La Jolla, CA |
| Adam Lynn Levin | Director | La Jolla, CA |
| Curtis Lynn Rosebraugh | Director | La Jolla, CA |
| Lee Lynn Rauch | Director | La Jolla, CA |
| William Lynn Chang | Director | La Jolla, CA |
| Andrew Lynn Benton | Director | La Jolla, CA |
| Steve Lynn Martin | Director | La Jolla, CA |
| Bob Lynn Gower | Director | La Jolla, CA |
Other filings by this issuer (6)
More